

Chlamydia is a preventable and curable sexually transmitted infection (STI) that can occur in men and women of all age groups. However, if left untreated, chlamydia infection can lead to serious health problems, including pelvic inflammatory disease (PID) and infertility in women. Chlamydia infection increases the risk of acquiring Human immunodeficiency virus infection (HIV) due to mucosal inflammation and easier viral entry. It has also been associated with adverse pregnancy outcomes, such as, preterm birth, low birth weight and neonatal infections (e.g., conjunctivitis, pneumonia). The Chlamydia Trachomatis - IgM antibody test helps in the detection and appropriate management of chlamydia infections.
The Chlamydia Trachomatis - IgM antibody test may be advised for individuals with symptoms suggestive of a Chlamydia trachomatis infection, such as pain or discomfort in the lower abdomen, vaginal/urethral discharge, a burning sensation when passing urine, or painful sexual intercourse. It can also be recommended for individuals at risk of STIs, such as those with a history of unprotected sexual activity, sexually active individuals, individuals with multiple sexual partners, or those with a history of STIs. Pregnant women may undergo this test as part of routine prenatal screening to identify any recent exposure to Chlamydia trachomatis and assess the risk of transmission of infection from the mother to the baby during delivery. Additionally, the Chlamydia Trachomatis - IgM antibody test can also be used to monitor the effectiveness of antibiotic treatment.
Usually, no special preparation is needed for this test. You may eat and drink as per your daily routine. However, it is preferred that you provide your clinical history before giving the sample.
A positive test result indicates the presence of IgM antibodies to Chlamydia trachomatis, suggesting an active or ongoing infection. However, a positive test result should be confirmed with a follow-up test (DNA PCR) to diagnose the infection. A negative test result suggests no active infection. However, sometimes, the results may be negative in the early stages of the infection when the level of antibodies is insufficient for detection.
Talk to your doctor about your specific test results. Narrate your complete medical history to help them correlate your clinical and laboratory findings. The test results will help the doctor make informed decisions about your sexual health.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab
The Chlamydia Trachomatis - IgM antibody test detects the presence of immunoglobulin (IgM) antibodies in the blood, which are produced by the immune system in response to a Chlamydia trachomatis infection. IgM antibodies are the first to appear when the body detects a new or active infection, making them a key indicator of recent exposure to the Chlamydia trachomatis bacteria. This test helps identify recent or ongoing chlamydia infections by detecting these early antibodies, usually within a few days to weeks after exposure. The presence of IgM antibodies can provide valuable information about the timing of the infection and guide healthcare providers in diagnosing and treating chlamydia.
The Chlamydia Trachomatis - IgM antibody test is done:
- To detect acute (active) or recent chlamydia infection.
- If you are experiencing symptoms suggestive of Chlamydia infection, such as genital discharge, pain, or a burning sensation during urination.
- To screen individuals at higher risk for Chlamydia infection, such as those who are sexually active or have multiple partners.
- To diagnose and manage complications related to chlamydia infection, such as pelvic inflammatory disease (PID) or infertility.
- To monitor the effectiveness of treatment for chlamydia infection.
- Following sexual exposure to a confirmed case of Chlamydia infection.
- Clinical history is required.























